Poll
Combination therapy with an SGLT2 inhibitor and GLP-1 receptor agonist:
Age May Modify Cardioprotective Effects of SGLT2 Inhibitors, GLP-1 RAs
Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access
Investigating the Link Between Type 2 Diabetes and Infection
Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
Tirzepatide Could Replace Daily Hormone Shots for Rare Genetic Fat Disorder
The HCPFive: Top News for Healthcare Providers from the Week of 1/26